Hongxia Zhang & Xiaojun Xia. (2021). RNA cancer vaccines: Developing mRNA nanovaccine with self-adjuvant property for cancer immunotherapy. Taylor & Francis Group.
Chicago Style (17th ed.) CitationHongxia Zhang and Xiaojun Xia. RNA Cancer Vaccines: Developing MRNA Nanovaccine with Self-adjuvant Property for Cancer Immunotherapy. Taylor & Francis Group, 2021.
MLA (9th ed.) CitationHongxia Zhang and Xiaojun Xia. RNA Cancer Vaccines: Developing MRNA Nanovaccine with Self-adjuvant Property for Cancer Immunotherapy. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.